Literature DB >> 16254995

Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance.

Gary Aston-Jones1, Jonathan D Cohen.   

Abstract

Historically, the locus coeruleus-norepinephrine (LC-NE) system has been implicated in arousal, but recent findings suggest that this system plays a more complex and specific role in the control of behavior than investigators previously thought. We review neurophysiological, anatomical, and modeling studies in monkey that support a new theory of LC-NE function. LC neurons exhibit two modes of activity, phasic and tonic. Phasic LC activation is driven by the outcome of task-related decision processes and is proposed to facilitate ensuing behaviors and to help optimize task performance. When utility in the task wanes, LC neurons exhibit a tonic activity mode, associated with disengagement from the current task and a search for alternative behaviors. Monkey LC receives prominent, direct inputs from the anterior cingulate (ACC) and orbitofrontal cortices (OFC), both of which are thought to monitor task-related utility. We propose that these prefrontal areas produce the above patterns of LC activity to optimize the utility of performance on both short and long time scales. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254995     DOI: 10.1002/cne.20723

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  207 in total

1.  Frequency dependence of vestibuloocular reflex thresholds.

Authors:  Csilla Haburcakova; Richard F Lewis; Daniel M Merfeld
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

Review 2.  Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?

Authors:  Abdalla Bowirrat; Thomas J H Chen; Marlene Oscar-Berman; Margaret Madigan; Amanda Lh Chen; John A Bailey; Eric R Braverman; Mallory Kerner; John Giordano; Siobhan Morse; B William Downs; Roger L Waite; Frank Fornari; Zaher Armaly; Kenneth Blum
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

3.  Orbitofrontal cortical activity during repeated free choice.

Authors:  Michael Campos; Kari Koppitch; Richard A Andersen; Shinsuke Shimojo
Journal:  J Neurophysiol       Date:  2012-03-14       Impact factor: 2.714

Review 4.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

5.  Beneficial effects of electrostimulation contingencies on sustained attention and electrocortical activity.

Authors:  Max Jean-Lon Chen; Trevor Thompson; Juri Kropotov; John H Gruzelier
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

Review 6.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

7.  Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions.

Authors:  Siri Leknes; Johan Wessberg; Dan-Mikael Ellingsen; Olga Chelnokova; Håkan Olausson; Bruno Laeng
Journal:  Soc Cogn Affect Neurosci       Date:  2012-05-29       Impact factor: 3.436

8.  Glutamate receptor subunit expression in the rhesus macaque locus coeruleus.

Authors:  Nigel C Noriega; Vasilios T Garyfallou; Steven G Kohama; Henryk F Urbanski
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

9.  Adrenergic α₁ receptor activation is sufficient, but not necessary for phrenic long-term facilitation.

Authors:  A G Huxtable; P M MacFarlane; S Vinit; N L Nichols; E A Dale; G S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2014-02-13

Review 10.  Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.

Authors:  Heiko Braak; Johannes Brettschneider; Albert C Ludolph; Virginia M Lee; John Q Trojanowski; Kelly Del Tredici
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.